Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Complications of SSRI treatment.

Walkup J, Labellarte M.

J Child Adolesc Psychopharmacol. 2001 Spring;11(1):1-4. No abstract available.

PMID:
11322738
2.

[Selective serotonin reuptake inhibitors (SSRI) in childhood and adolescence].

Stilke D.

Z Kinder Jugendpsychiatr Psychother. 1997 May;25(2):106-16. Review. German. No abstract available.

PMID:
9459700
3.

[Therapy with selective serotonin reuptake inhibitors (SSRI). Indications, uses and risks].

Ebert D.

Fortschr Med. 1996 Jul 1;114(18-19):243-7. Review. German.

PMID:
8766793
4.

Selective serotonin reuptake inhibitors (SSRIs) in children and adolescents.

Vitiello B.

J Child Adolesc Psychopharmacol. 2006 Feb-Apr;16(1-2):7-9. No abstract available.

PMID:
16553524
6.

Potential indications for the selective serotonin reuptake inhibitors.

Boyer WF.

Int Clin Psychopharmacol. 1992 Jun;6 Suppl 5:5-12. Review.

PMID:
1431022
7.

Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors.

Grzeskowiak LE, Gilbert AL, Morrison JL.

J Clin Psychopharmacol. 2012 Oct;32(5):615-21. doi: 10.1097/JCP.0b013e31826686bc.

PMID:
22926594
8.

SSRI-induced apathy syndrome: a clinical review.

Barnhart WJ, Makela EH, Latocha MJ.

J Psychiatr Pract. 2004 May;10(3):196-9. Review.

PMID:
15330228
9.

Improved outcome in fluvoxamine-treated patients with SSRI-induced sexual dysfunction.

Banov MD.

J Clin Psychiatry. 1999 Dec;60(12):866-8. No abstract available.

PMID:
10665636
10.

Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors.

Skop BP, Brown TM.

Psychosomatics. 1996 Jan-Feb;37(1):12-6. Review.

PMID:
8600488
11.

Selective serotonin reuptake inhibitors for children and adolescents.

Kastelic EA, Labellarte MJ, Riddle MA.

Curr Psychiatry Rep. 2000 Apr;2(2):117-23. Review.

PMID:
11122943
12.

SSRI antidepressants: Medsafe's response to Professor Werry's letter.

Jessamine S.

N Z Med J. 2008 Mar 14;121(1270):97-101. No abstract available.

PMID:
18364761
13.

Sensory disturbances associated with serotonin reuptake inhibitors: brief review.

Praharaj SK, Arora M, Sarkhel S.

Hum Psychopharmacol. 2010 Apr;25(3):216-21. doi: 10.1002/hup.1109. Review.

PMID:
20373472
14.

Benefits exceed risks of newer antidepressant medications in youth--maybe not.

Potter WZ.

Clin Pharmacol Ther. 2009 Oct;86(4):357-9. doi: 10.1038/clpt.2009.173. No abstract available.

PMID:
19763114
15.

Benefits exceed risks of newer antidepressant medications in youth--maybe.

March JS, Vitiello B.

Clin Pharmacol Ther. 2009 Oct;86(4):355-7. doi: 10.1038/clpt.2009.172. No abstract available.

PMID:
19763113
16.

Therapy for the brain and gut.

Szigethy E.

J Psychiatr Pract. 2005 Jan;11(1):51-3. No abstract available.

PMID:
15650622
17.

Reversible nocturnal enuresis in children receiving SSRI with or without risperidone: presentation of five cases.

Kandil ST, Aksu HB, Ozyavuz R.

Isr J Psychiatry Relat Sci. 2004;41(3):218-21.

PMID:
15754526
18.

Combined serotonin syndrome and hyponatraemia caused by a citalopram-buspirone interaction.

Spigset O, Adielsson G.

Int Clin Psychopharmacol. 1997 Jan;12(1):61-3. No abstract available.

PMID:
9179637
19.

SSRI prescription rates after a terrorist attack.

DiMaggio C, Galea S, Madrid P.

Psychiatr Serv. 2006 Nov;57(11):1656-7. No abstract available.

PMID:
17085620
20.

Beyond specificity: effects of serotonin and serotonergic treatments on psychobiological dysfunction.

Dubovsky SL, Thomas M.

J Psychosom Res. 1995 May;39(4):429-44. Review.

PMID:
7562673
Items per page

Supplemental Content

Write to the Help Desk